In a cohort of 498 well‐characterized NB cases (GSE62564), Kaplan‐Meier survival analysis demonstrated that lower expression of RBM10 (p = 2.1 × 10−7) and elevated levels of NR1D1 (p = 2.3 × 10−7), RIOK3 (p = 1.8 × 10−6), FLCN (p = 7.6 × 10−20), or FNIP1 (p = 4.6 × 10−2) was correlated with improved clinical outcomes (Figure S12D, Supporting Information). Here, RBM10 is linked to neuroblastoma.